Plant Comparison
Cordyceps vs Purple coneflower
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Cordyceps and Purple coneflower: they share 5 indicated uses (arthritis / joint pain, cold & flu, immune support, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Cordyceps | Purple coneflower | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 1/10 | Stronger for Cordyceps |
| Cold & flu | 5/10 | 1/10 | Stronger for Cordyceps |
| Immune support | 5/10 | 1/10 | Stronger for Cordyceps |
| Inflammation (general) | 5/10 | 1/10 | Stronger for Cordyceps |
| Skin irritation | 5/10 | 1/10 | Stronger for Cordyceps |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
A nucleoside analogue considered the marker bioactive compound, studied for anti-inflammatory, antioxidant and metabolic effects.
Immunomodulatory and antioxidant polysaccharides, a major focus of both oral and topical product development.
Additional characteristic fungal sterol and nucleoside constituents.
Lipophilic alkamides are considered key immunomodulatory and anti-inflammatory constituents, particularly concentrated in the root.
Antioxidant phenolic compounds contributing to the plant's immunomodulatory activity.
Water-soluble polysaccharides associated with immune-stimulating activity, particularly from the aerial parts.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from immunomodulator action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Generally well tolerated short-term in human studies, but research is still limited (Ontawong et al., 2024; Hirsch et al., 2016). Possible side effects: stomach upset, nausea, diarrhea, headache (reported broadly for “Cordyceps” supplements; not everyone gets this) (Jędrejko, Lazur and Muszyńska, 2021). Avoid / use medical guidance if you have: autoimmune disease, you’re on immunosuppressants, you have a bleeding disorder, or you take blood thinners/antiplatelet drugs (theoretical interaction + caution used in reviews) (Jędrejko, Lazur and Muszyńska, 2021). Pregnancy/lactation: not enough safety data → best to avoid (Jędrejko, Lazur and Muszyńska, 2021). Quality matters: choose reputable brands with testing for contaminants and clear labeling (fruiting body vs mycelium; extract ratio) (Jędrejko et al., 2022).
Generally considered safe, but caution advised for those with autoimmune conditions. Not recommended for long-term use (more than 8 weeks continuously).
Duke (2002) rates echinacea as +++ — among the most thoroughly documented herbal immunostimulants. It notes experimental and clinical evidence for immunostimulant, antiviral, and anti-inflammatory activities. Multiple species have been studied (E. purpurea, E. angustifolia, E. pallida), and Duke emphasizes that species identification in commercial products is often unreliable. Commission E approves E. purpurea for supporting immune function during colds and flu. Dose: 900 mg standardized extract daily in acute use; use should be limited to 8 weeks continuous. Contraindicated in autoimmune diseases (MS, lupus, HIV/AIDS), tuberculosis, and with immunosuppressive drugs (cyclosporine) (Duke, 2002).
External Ids
Botanical Description
Entomopathogenic fungus (not a true plant) that develops from a mycelium infecting and consuming an insect host - classically a moth caterpillar or pupa buried in the soil. In late season it produces a slender, bright orange, club-shaped fruiting body (stroma) that emerges from the ground above the mummified host, its surface minutely roughened with embedded spore-producing structures.[4]
Robust perennial herb with a basal rosette of coarse, hairy, lance-shaped leaves and tall, sturdy flowering stems. Each stem bears a single large, daisy-like flower head with drooping (reflexed), rose-purple to pink ray florets surrounding a prominent, spiny, orange-brown central cone of disc florets.[4]
Habitat
Grows on insect larvae and pupae in cool, moist forest soils and grassland across temperate and alpine East Asia; commercially, most Cordyceps militaris is now cultivated on grain or insect-based substrate rather than wild-collected.[4]
Native to the tallgrass prairies, open woodland and dry meadows of central and eastern North America; widely cultivated worldwide as a garden and medicinal plant.[4]
Harvesting
Wild fruiting bodies are dug up carefully with the insect host attached, in autumn when they emerge; cultivated material is harvested from the growing substrate once the orange fruiting bodies mature, then dried.
The flower heads are picked as they open, in summer; the root is dug in autumn from plants at least two to three years old, when its content of bioactive alkamides and caffeic acid derivatives is highest, then cleaned and dried.[4]
Traditional Uses
Echinacea root was widely used by Native American peoples as a remedy for infections, wounds, snakebite and toothache, and entered nineteenth-century Eclectic medicine as a broad anti-infective. It remains best known today, in standardised aerial-part or root extracts, as a supportive remedy for preventing and shortening the common cold and supporting immune function.[1, 4]
Preparations
Cultivated fruiting-body extract, standardised to cordycepin or polysaccharide content, taken as capsules or powder.
Fresh-pressed juice or standardised extract of the aerial parts or root, taken as tablets, drops or capsules at the first sign of a cold; the best-studied clinical form.
References
Lookalikes Review
Dangerous Lookalikes
Not documented
Dosage
Not documented
Clinical trials for the common cold commonly use around 300-900 mg of standardised extract daily, started at the first sign of symptoms and continued for up to 7-10 days; continuous use beyond about 8 weeks is not recommended. Educational reference only, not a prescription.
Drug Class Interactions
Not documented
References & Sources
- Lan, T., Yu, Y., Zhang, J., Li, H. et al (2021) 'Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway', Hepatology, 74(2), pp. 686-703. doi:10.1002/hep.31749 Preclinical
https://doi.org/10.1002/hep.31749 - Wei, P., Wang, K., Luo, C., Huang, Y. et al (2021) 'Cordycepin confers long-term neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury', Journal of Neuroinflammation, 18(1), pp. 137. doi:10.1186/s12974-021-02188-x Preclinical
https://doi.org/10.1186/s12974-021-02188-x - Tan, L., Song, X., Ren, Y., Wang, M. et al (2020) 'Anti-inflammatory effects of cordycepin: A review', Phytotherapy Research. doi:10.1002/ptr.6890 Traditional / reference
https://doi.org/10.1002/ptr.6890 - Kanlayavattanakul, M. and Lourith, N (2023) 'Cordyceps militaris polysaccharides: preparation and topical product application', Fungal Biology and Biotechnology, 10(1), pp. 3. doi:10.1186/s40694-023-00150-5 Meta-analysis / review
https://doi.org/10.1186/s40694-023-00150-5 - Yang, W., Fu, C., Hu, B., Yan, Y. and Cheng, Y (2024) 'Five undescribed cyclopeptides from Cordyceps militaris', Phytochemistry, 222, pp. 114074. doi:10.1016/j.phytochem.2024.114074 Preclinical
https://doi.org/10.1016/j.phytochem.2024.114074 - Miao, M., Yu, W., Li, Y., Sun, Y. and Guo, S (2022) 'Structural elucidation and activities of Cordyceps militaris-derived polysaccharides: a review', Frontiers in Nutrition, 9, pp. 898674. doi:10.3389/fnut.2022.898674 Meta-analysis / review
https://doi.org/10.3389/fnut.2022.898674 - Jedrejko, K.J., Lazur, J. and Muszynska, B (2021) 'Cordyceps militaris: an overview of its chemical constituents in relation to biological activity', Foods, 10(11), pp. 2634. doi:10.3390/foods10112634 Meta-analysis / review
https://doi.org/10.3390/foods10112634 - Malucka, L.U., Uhrinova, A. and Lysinova, P (2022) 'Medicinal mushrooms Ophiocordyceps sinensis and Cordyceps militaris', Ceska a Slovenska Farmacie, 71(6), pp. 259-265. doi:10.5817/csf2022-5-259 Meta-analysis / review
https://doi.org/10.5817/csf2022-5-259 - Sun, J., Jin, M., Zhou, W., Diao, S., Zhou, Y., Li, S., Wang, X., Pan, S., Jin, X. and Li, G (2017) 'A new ribonucleotide from Cordyceps militaris', Natural Product Research, 31(21), pp. 2537-2543. doi:10.1080/14786419.2017.1323210 Preclinical
https://doi.org/10.1080/14786419.2017.1323210 - Choi, E., Oh, J. and Sung, G.H (2020) 'Antithrombotic and antiplatelet effects of Cordyceps militaris', Mycobiology, 48(3), pp. 228-232. doi:10.1080/12298093.2020.1763115 Preclinical
https://doi.org/10.1080/12298093.2020.1763115 - Zhang, J., Wen, C., Duan, Y., Zhang, H. and Ma, H (2019) 'Advance in Cordyceps militaris (Linn) Link polysaccharides: isolation, structure, and bioactivities: a review', International Journal of Biological Macromolecules, 132, pp. 906-914. doi:10.1016/j.ijbiomac.2019.04.020 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2019.04.020 - Chiu, C.P., Liu, S.C., Tang, C.H., Chan, Y., El-Shazly, M., Lee, C.L., Du, Y.C., Wu, T.Y., Chang, F.R. and Wu, Y.C (2016) 'Anti-inflammatory cerebrosides from cultivated Cordyceps militaris', Journal of Agricultural and Food Chemistry, 64(7), pp. 1540-1548. doi:10.1021/acs.jafc.5b05931 Preclinical
https://doi.org/10.1021/acs.jafc.5b05931 - Chamyuang, S., Owatworakit, A. and Honda, Y (2019) 'New insights into cordycepin production in Cordyceps militaris and applications', Annals of Translational Medicine, 7(Suppl 3), pp. S78. doi:10.21037/atm.2019.04.12 Meta-analysis / review
https://doi.org/10.21037/atm.2019.04.12 - Cui, J.D (2015) 'Biotechnological production and applications of Cordyceps militaris, a valued traditional Chinese medicine', Critical Reviews in Biotechnology, 35(4), pp. 475-484. doi:10.3109/07388551.2014.900604 Meta-analysis / review
https://doi.org/10.3109/07388551.2014.900604 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Zhu, J.S., Halpern, G.M. and Jones, K (1998) 'The scientific rediscovery of a precious ancient Chinese herbal regimen: Cordyceps sinensis', 4(3), pp. 289--303. doi:10.1089/acm.1998.4.429 Randomized trial
https://doi.org/10.1089/acm.1998.4.429 - Hirsch, K.R., Smith-Ryan, A.E., Roelofs, E.J., Trexler, E.T. and Mock, M.G (2017) 'Cordyceps militaris improves tolerance to high-intensity exercise after acute and chronic supplementation', 14(1), pp. 42--53. doi:10.1080/19390211.2016.1203386 Randomized trial
https://doi.org/10.1080/19390211.2016.1203386 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Chemistry World (Royal Society of Chemistry) 'Poisons leave no mushroom for error'. Available at: https://www.chemistryworld.com/opinion/poisons-leave-no-mushroom-for-error/4011376.article Traditional / reference
https://www.chemistryworld.com/opinion/poisons-leave-no-mushroom-for-error/4011376.article - Choe, S. and In, S. and Jeon, Y. and Choi, H. and Kim, S (2018) 'Identification of trichothecene-type mycotoxins in toxic mushroom Podostroma cornu-damae and biological specimens from a fatal case by LC-QTOF/MS', Forensic Science International, 291, pp. 234-244. doi:10.1016/j.forsciint.2018.08.043 Clinical study
https://doi.org/10.1016/j.forsciint.2018.08.043 - Ahn, J.Y. and Seok, S.J. and Song, J.E. and Choi, J.H. and Han, S.H. and Choi, J.Y. and Kim, C.O. and Song, Y.G. and Kim, J.M (2013) 'Two cases of mushroom poisoning by Podostroma cornu-damae', Yonsei Medical Journal, 54(1), pp. 265-8. doi:10.3349/ymj.2013.54.1.265 Clinical study
https://doi.org/10.3349/ymj.2013.54.1.265
- Karsch-Völk, M., Barrett, B., Kiefer, D., Bauer, R. et al (2014) 'Echinacea for preventing and treating the common cold', Cochrane Database of Systematic Reviews, 2(2), pp. CD000530. doi:10.1002/14651858.CD000530.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD000530.pub3 - Kamin, W., Seifert, G., Zwiauer, K., Bonhoeffer, J. et al (2025) 'Phytotherapy for acute respiratory tract infections in children: a systematically conducted, comprehensive review', Frontiers in Pediatrics, 13, pp. 1423250. doi:10.3389/fped.2025.1423250 Meta-analysis / review
https://doi.org/10.3389/fped.2025.1423250 - Fashner, J., Ericson, K. and Werner, S (2012) 'Treatment of the common cold in children and adults', American Family Physician, 86(2), pp. 153-159. Available at: https://pubmed.ncbi.nlm.nih.gov/22962927/ Traditional / reference
https://pubmed.ncbi.nlm.nih.gov/22962927/ - Manayi, A., Vazirian, M. and Saeidnia, S (2015) 'Echinacea purpurea: Pharmacology, phytochemistry and analysis methods', Pharmacognosy Reviews, 9(17), pp. 63-72. doi:10.4103/0973-7847.156353 Meta-analysis / review
https://doi.org/10.4103/0973-7847.156353 - Burlou-Nagy, C., Banica, F., Jurca, T., Vicas, L.G., Marian, E., Muresan, M.E., Bacskay, I., Kiss, R., Feher, P. and Pallag, A (2022) 'Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review', Plants, 11(9), pp. 1244. doi:10.3390/plants11091244 Meta-analysis / review
https://doi.org/10.3390/plants11091244 - Hall, H., Fahlman, M.M. and Engels, H.J (2007) 'Echinacea purpurea and mucosal immunity', International Journal of Sports Medicine, 28(9), pp. 792-797. doi:10.1055/s-2007-964895 Randomized trial
https://doi.org/10.1055/s-2007-964895 - Ross, S.M (2016) 'Echinacea purpurea: A Proprietary Extract of Echinacea purpurea Is Shown to be Safe and Effective in the Prevention of the Common Cold', Holistic Nursing Practice, 30(1), pp. 54-57. doi:10.1097/HNP.0000000000000130 Meta-analysis / review
https://doi.org/10.1097/HNP.0000000000000130 - Hudson, J.B (2011) 'Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases', Journal of Biomedicine & Biotechnology, 2012, pp. 769896. doi:10.1155/2012/769896 Meta-analysis / review
https://doi.org/10.1155/2012/769896 - Mishima, S., Saito, K., Maruyama, H., Inoue, M., Yamashita, T., Ishida, T. and Gu, Y (2004) 'Antioxidant and immuno-enhancing effects of Echinacea purpurea', Biological & Pharmaceutical Bulletin, 27(7), pp. 1004-1009. doi:10.1248/bpb.27.1004 Preclinical
https://doi.org/10.1248/bpb.27.1004 - Saunders, P.R., Smith, F. and Schusky, R.W (2007) 'Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections', Canadian Journal of Physiology and Pharmacology, 85(11), pp. 1195-1199. doi:10.1139/Y07-103 Clinical study
https://doi.org/10.1139/Y07-103 - Micheli, L., Maggini, V., Ciampi, C., Gallo, E., Bogani, P., Fani, R., Pistelli, L., Ghelardini, C., Di Cesare Mannelli, L., De Leo, M. and Firenzuoli, F (2022) 'Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy', Phytotherapy Research, 37(5), pp. 1911-1923. doi:10.1002/ptr.7709 Preclinical
https://doi.org/10.1002/ptr.7709 - Gholami, M., Amri, J., Pazhoohan, S. and Sadegh, M (2021) 'Anticonvulsive and anti-epileptogenesis effects of Echinacea purpurea root extract, an involvement of CB2 receptor', Journal of Complementary & Integrative Medicine, 19(4), pp. 879-886. doi:10.1515/jcim-2020-0219 Preclinical
https://doi.org/10.1515/jcim-2020-0219 - Awortwe, C., Bruckmueller, H., Kaehler, M. and Cascorbi, I (2021) 'Interaction of Phytocompounds of Echinacea purpurea with ABCB1 and ABCG2 Efflux Transporters', Molecular Pharmaceutics, 18(4), pp. 1622-1633. doi:10.1021/acs.molpharmaceut.0c01075 Preclinical
https://doi.org/10.1021/acs.molpharmaceut.0c01075 - Perry, N.B., van Klink, J.W., Burgess, E.J. and Parmenter, G.A (1997) 'Alkamide levels in Echinacea purpurea: a rapid analytical method revealing differences among roots, rhizomes, stems, leaves and flowers', Planta Medica, 63(1), pp. 58-62. doi:10.1055/s-2006-957605 Preclinical
https://doi.org/10.1055/s-2006-957605 - Linde, K., Barrett, B., Wölkart, K., Bauer, R. and Melchart, D (2006) 'Echinacea for preventing and treating the common cold'. Traditional / reference
https://scholar.google.com/scholar?q=Echinacea%20for%20preventing%20and%20treating%20the%20common%20cold - Sharma, M., Schoop, R., Suter, A. and Schoop, W (2010) 'The possibility of prophylactic treatment of streptococcal pharyngotonsillitis with a standardized Echinacea preparation', 29(8), pp. 1025--1035. Traditional / reference
https://scholar.google.com/scholar?q=The%20possibility%20of%20prophylactic%20treatment%20of%20streptococcal%20pharyngotonsillitis%20with%20a%20standardized%20Echinacea%20preparation - World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Gorski, J.C., Huang, S.M., Pinto, A., Hamman, M.A., Hilligoss, J.K., Zaheer, N.A., Desai, M., Miller, M. and Hall, S.D (2004) 'The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo', Clinical Pharmacology and Therapeutics, 75(1), pp. 89-100. doi:10.1016/j.clpt.2003.09.013 Clinical study
https://doi.org/10.1016/j.clpt.2003.09.013
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.